Key statistics
On Friday, SAGE Therapeutics Inc (SAGE:NMQ) closed at 6.31, 11.88% above the 52 week low of 5.64 set on Nov 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.33 |
---|---|
High | 6.39 |
Low | 6.17 |
Bid | 5.91 |
Offer | 6.31 |
Previous close | 6.32 |
Average volume | 977.66k |
---|---|
Shares outstanding | 61.17m |
Free float | 53.89m |
P/E (TTM) | -- |
Market cap | 386.00m USD |
EPS (TTM) | -5.58 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
- Sage Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Pipeline and Business Updates
- Sage Therapeutics Announces Strategic Reorganization to Prioritize ZURZUVAE® Commercialization and Focus its Development Portfolio
- Sage Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024
- Sage Therapeutics Announces Topline Results from the Phase 2 LIGHTWAVE Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment and Mild Dementia in Alzheimer’s Disease
- Sage Therapeutics Announces Discontinuation of the Collaboration with Biogen on the SAGE-324 Program
More ▼